Form 4 for CRL Charles River Laboratories
Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-18 · accession 0001127602-22-006257 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-02-23 | 2022-02-18+ | CRL | WALLMAN RICHARD F | Dir | S - Sale | $292.42 | -6,050 | 3,250 | -65% | -$1.77M |
| M | 2022-02-23 | 2022-02-18 | CRL | WALLMAN RICHARD F | Dir | S - Sale | $295.00 | -1,150 | 18.4K | -6% | -$339.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | S | D | 3,250 | $288.05 | 0 | I | — | — | |
| 2 | Common | Common Stock | 2022-02-18 | S | D | 725 | $295.00 | 17,679 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-18 | S | D | 2,800 | $297.50 | 3,250 | I By Wife | — | — | |
| 4 | Common | Common Stock | 2022-02-18 | S | D | 425 | $295.00 | 18,404 | D By Wife | — | — |